PFS Investments’s Pfizer PFE Stock Holding History

PFS Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.69M	Buy	155,215 +7,550	+5%	+$294K	0.09%	202
2023 Q1	$6.13M	Buy	147,665 +4,543	+3%	+$196K	0.11%	175
2022 Q4	$7.33M	Buy	143,122 +9,447	+7%	+$453K	0.14%	145
2022 Q3	$5.85M	Buy	133,675 +5,281	+4%	+$257K	0.11%	158
2022 Q2	$6.73M	Buy	128,394 +14,074	+12%	+$717K	0.14%	152
2022 Q1	$5.92M	Buy	114,320 +10,570	+10%	+$548K	0.11%	171
2021 Q4	$6.13M	Buy	103,750 +5,257	+5%	+$260K	0.12%	166
2021 Q3	$4.76M	Buy	98,493 +2,604	+3%	+$115K	0.1%	184
2021 Q2	$3.8M	Buy	95,889 +2,442	+3%	+$95K	0.09%	194
2021 Q1	$3.39M	Buy	93,447 +3,814	+4%	+$135K	0.09%	191
2020 Q4	$3.38M	Buy	89,633 +4,676	+6%	+$172K	0.1%	176
2020 Q3	$2.96M	Buy	84,957 +7,036	+9%	+$247K	0.1%	164
2020 Q2	$2.42M	Buy	77,921 +14,245	+22%	+$484K	0.09%	153
2020 Q1	$1.97M	Buy	63,676 +28,449	+81%	+$969K	0.09%	151
2019 Q4	$1.31M	Buy	35,227 +16,140	+85%	+$575K	0.05%	175
2019 Q3	$651K	Buy	19,087 +9,510	+99%	+$346K	0.03%	173
2019 Q2	$399K	Buy	+9,577	New	+$380K	0.02%	163

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PFS Investments's PFE Position: Q2 2023 in Review

PFS Investments increased its Pfizer (PFE) stake by 5.1% in Q2 2023, buying an estimated $294K and bringing the position to 155,215 shares worth $5.69M. The position accounts for 0.09% of the portfolio, ranked #202.

PFS Investments first reported a position in PFE in Q2 2019 and has held it in 17 quarters since. The position peaked at $7.33M in Q4 2022. 3,044 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

PFS Investments held 155,215 shares of Pfizer worth $5.69M as of Q2 2023.
PFS Investments bought 7,550 Pfizer shares in Q2 2023, an estimated $294K.
Pfizer made up 0.09% of PFS Investments's portfolio in Q2 2023, its #202 holding.
PFS Investments first reported a position in Pfizer in Q2 2019 and has held it in 17 quarters since.
PFS Investments's Pfizer position peaked at $7.33M in Q4 2022.
3,044 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.